Literature DB >> 10762168

A single nucleotide polymorphism of dopamine transporter gene is associated with Parkinson's disease.

H Morino1, T Kawarai, Y Izumi, T Kazuta, M Oda, O Komure, F Udaka, M Kameyama, S Nakamura, H Kawakami.   

Abstract

We identified two polymorphisms out of all coding regions of the dopamine transporter gene. One existed in exon 9 (1215A/G) and another in exon 15 (1898T/C). The 1215G was significantly less frequent among patients with Parkinson's disease than the controls. Although the polymorphism caused no amino acid substitution, we concluded that it was associated with decreasing the susceptibility to Parkinson's disease through mechanisms other than the protein function of dopamine transporter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762168

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  7 in total

1.  SLC6A3 is a risk factor for Parkinson's disease: a meta-analysis of sixteen years' studies.

Authors:  Desheng Zhai; Songji Li; Ying Zhao; Zhicheng Lin
Journal:  Neurosci Lett       Date:  2013-11-07       Impact factor: 3.046

Review 2.  From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes.

Authors:  Alessandro Serretti; Paola Artioli
Journal:  Psychopharmacology (Berl)       Date:  2004-03-02       Impact factor: 4.530

3.  Polymorphism in environment responsive genes and association with Parkinson disease.

Authors:  Madhu Singh; Anwar J Khan; Parag P Shah; Rakesh Shukla; V K Khanna; Devendra Parmar
Journal:  Mol Cell Biochem       Date:  2008-03-09       Impact factor: 3.396

4.  No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson's disease in nine ADHD candidate SNPs.

Authors:  Julia M Geissler; Marcel Romanos; Manfred Gerlach; Daniela Berg; Claudia Schulte
Journal:  Atten Defic Hyperact Disord       Date:  2017-02-07

5.  Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.

Authors:  Małgorzata Michałowska; Małgorzata Chalimoniuk; Ewa Jówko; Iwona Przybylska; Józef Langfort; Beata Toczylowska; Anna Krygowska-Wajs; Urszula Fiszer
Journal:  Brain Behav       Date:  2020-02-05       Impact factor: 2.708

6.  Polymorphism in the Vesicular Monoamine Transporter 2 Gene Decreases the Risk of Parkinson's Disease in Han Chinese Men.

Authors:  Xinglong Yang; Pingrong Xu; Quanzhen Zhao; Ran An; Hua Jia; Zhuolin Liu; Yanming Xu
Journal:  Parkinsons Dis       Date:  2015-07-12

7.  Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson's Disease.

Authors:  Jolanta Dorszewska; Michal Prendecki; Anna Oczkowska; Agata Rozycka; Margarita Lianeri; Wojciech Kozubski
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.